As a Théa’s dedicated business unit, Sepul Bio is at the forefront of transformative RNA therapies for inherited retinal diseases, with a particular focus on the development of two cutting-edge ophthalmic medicines – Sepofarsen and Ultevursen.
Consult our Social Media Community Guidelines: https://bit.ly/48pUFKm
Company Details
- Employees
- 14
- Founded
- -
- Address
- Debilitating Conditions Like Ush2a-Associated Retinitis Pigmentosa Click The Link In The Comments 👇
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Sepul Bio Questions
Sepul Bio's LinkedIn profile is https://www.linkedin.com/company/sepulbio
Sepul Bio has
14 employees.
View email and phone details for 14
employees at Sepul Bio.
Sepul Bio's industry is
Biotechnology Research
Sepul Bio's categories are Biotechnology Research
Sepul Bio's founding year is 2023
